Cigliola, Valentina http://orcid.org/0000-0002-1596-7332
Shoffner, Adam
Lee, Nutishia
Ou, Jianhong http://orcid.org/0000-0002-8652-2488
Gonzalez, Trevor J.
Hoque, Jiaul
Becker, Clayton J. http://orcid.org/0000-0002-1127-0618
Han, Yanchao
Shen, Grace
Faw, Timothy D. http://orcid.org/0000-0001-7794-0074
Abd-El-Barr, Muhammad M.
Varghese, Shyni http://orcid.org/0000-0002-0004-7947
Asokan, Aravind http://orcid.org/0000-0001-5563-4877
Poss, Kenneth D. http://orcid.org/0000-0002-6743-5709
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (R21 NS124635)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R35 HL150713)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (P2GEP3_175016, P400PM_186709)
Article History
Received: 27 June 2023
Accepted: 26 July 2023
First Online: 11 August 2023
Competing interests
: V.C., A.S., and K.D.P. are listed as inventors on a patent application filed by Duke University on use of Hb-egf for spinal cord regeneration. Other authors declare no competing interests.